Trial intelligence / Profile preview

DOSIDO: Warfarin Reinitiation

NCT01348074Phase 2Completed

Sponsor
McMaster University
Start
Apr 2011
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of warfarin in Atrial fibrillation (AFib), venous thromboembolism (VTE), heart valve disease, sponsored by McMaster University. Started Apr 2011; status: completed.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)venous thromboembolism (VTE)heart valve disease

Beyond the preview

Go deeper on NCT01348074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01348074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call